Dava Stewart

“These cases highlight a potential association between erlotinib therapy and bilateral, acute, simultaneous-onset anterior uveitis and suggest some patients may respond to topical corticosteroids, despite continued use of the drug.”

Antimicrobial treatment is the most important modifiable risk factor for clostridium difficile infection (CDI) in hemato-oncological patients, according to a recent study. The researchers conclude that chemotherapy itself is not a risk factor for CDI in this patient population.

Patients who are taking it and are pregnant or plan to become pregnant “are currently advised to balance the potential benefits and potential risks of exposure when considering treatment options,” say the authors.

Siponimod continues to look promising for multiple sclerosis. Researchers report good results on three-year extension of BOLD study.

Researchers say they have found a new and potentially cheaper and better way to diagnose HCV.

Criminal cyber attacks on healthcare institutions are on the rise. How can hospitals prevent them? Experts offer strategies.

Lymphopenia may identify an immunologically distinct subset of MS, researchers report.

Are people with atopic dermatitis at a higher or lower risk of developing skin cancer? Researchers found conflicting evidence.

Genetic analysis can assess the risk of getting multiple sclerosis (MS), but not how severe the disease would be, according to the results of a recent meta-analysis.

In the past 15 years, no new topical AD treatments have been approved. Crisaborole, however, could be an efficient, safe, non-steoidal treatment option, according to the results of two recent phase III studies.

A better understanding of myeloid cells and their role in the immunopathology of multiple sclerosis (MS) could lead to therapeutic interventions that improve the prognosis of MS,

Pharmacogenetics may be the key to providing individualized treatment to patients who become anemic after hepatitis C treatment, according to a recent review

“Although further development of faldaprevir in combination with deleobuvir was terminated due to a strategic decision,” the present study provides valuable information about “antiviral therapies that include a combination of DAAs with a PI and a non-nucleoside thumb-pocket 1 polymerase inhibitor.”

Although direct acting antivirals (DAAs) have revolutionized the treatment of hepatitis C virus (HCV), a small fraction of patients still experience treatment failure.

Options for treating atopic dermatitis topically are far too limited, a review has found.

Patients in the United Kingdom who have been frequently admitted to the hospital for asthma benefit from a multidisciplinary team approach, according to the results of a recent study.

Perceived stress and atopic dermatitis (AD) are associated, a Korean study finds.

Researchers are investigating the possibility the upregulation of regulatory T (Treg) cells as a new therapy to persistently alleviate asthma. A mouse study yields promising results.

Neurofilament lightchain level may be a biomarker for other conditions, but it is weak as an independent risk factor for multiple sclerosis, researchers report.

Early treatment benefits MS patients, another study has found.

Despite the arrival of direct acting antivirals, there are limit options for patients with genotypes 2 and 3 of HCV infection. A drug combo using interferon appears to work, a study finds.

An electronic alert system may lead physicians to put more Afib patients on anti-coagulants.

“In this current investigation, the two most statistically significant findings were that higher HbA2 levels correlated with higher RBC levels and prominently lesser MSSS [multiple sclerosis severity score].”

RNS60, a charge-stabilized nanostructure, shows potential as a beneficial therapy for demyelinating conditions, such as multiple sclerosis (MS), according to the results of a recent study.

Men over the age of 50 who have human immunodeficiency virus (HIV) and who are adherent to an antiretroviral therapy (ART) regimen are at risk for cognitive decline, according to the results of a recent study.

“On the basis of evidence currently available, IL-1 RA is an attractive candidate drug for clinical trial.” Interleukin-1 is an anti-inflammatory protein typically used to treat rheumatoid arthritis.

“Each entry contains contextual information pertaining to the entry such as the HCV genotypic background and links to the original publication,” say the authors.

There are differences in the tissue sodium signal and the fluid-attenuated sodium signal in the brain lesions of patients with acute multiple sclerosis (MS) and those with chronic MS, according to a recent study.

Quantitative magnetic resonance imaging (qMRI) may be a good tool for assessing disease status among patients with secondary progressive multiple sclerosis (SPMS), according to the results of a study published in the journal PLOS One